Nitroalkenes Confer Acute Cardioprotection Via Adenine Nucleotide Translocase 1
Overview
Authors
Affiliations
Electrophilic nitrated lipids (nitroalkenes) are emerging as an important class of protective cardiovascular signaling molecules. Although species such as nitro-linoleate (LNO(2)) and nitro-oleate can confer acute protection against cardiac ischemic injury, their mechanism of action is unclear. Mild uncoupling of mitochondria is known to be cardioprotective, and adenine nucleotide translocase 1 (ANT1) is a key mediator of mitochondrial uncoupling. ANT1 also contains redox-sensitive cysteines that may be targets for modification by nitroalkenes. Therefore, in this study we tested the hypothesis that nitroalkenes directly modify ANT1 and that nitroalkene-mediated cardioprotection requires ANT1. Using biotin-tagged LNO(2) infused into intact perfused hearts, we obtained mass spectrometric (MALDI-TOF-TOF) evidence for direct modification (nitroalkylation) of ANT1 on cysteine 57. Furthermore, in a cell model of ischemia-reperfusion injury, siRNA knockdown of ANT1 inhibited the cardioprotective effect of LNO(2). Although the molecular mechanism linking ANT1-Cys(57) nitroalkylation and uncoupling is not yet known, these data suggest that ANT1-mediated uncoupling may be a mechanism for nitroalkene-induced cardioprotection.
Revol-Cavalier J, Quaranta A, Newman J, Brash A, Hamberg M, Wheelock C Chem Rev. 2024; 125(1):1-90.
PMID: 39680864 PMC: 11719350. DOI: 10.1021/acs.chemrev.3c00520.
Gunther M, Dabare S, Fuchs J, Gunesch S, Hofmann J, Decker M Antioxidants (Basel). 2024; 13(1).
PMID: 38247469 PMC: 10812788. DOI: 10.3390/antiox13010044.
Nitrated Fatty-Acids Distribution in Storage Biomolecules during Development.
Aranda-Cano L, Valderrama R, Chaki M, Begara-Morales J, Melguizo M, Barroso J Antioxidants (Basel). 2022; 11(10).
PMID: 36290592 PMC: 9598412. DOI: 10.3390/antiox11101869.
Redox Regulation of Soluble Epoxide Hydrolase-Implications for Cardiovascular Health and Disease.
Charles R, Eaton P Cells. 2022; 11(12).
PMID: 35741062 PMC: 9221603. DOI: 10.3390/cells11121932.
Lipid nitroalkene nanoparticles for the focal treatment of ischemia reperfusion.
Yu G, Ramasamy T, Fazzari M, Chen X, Freeman B, Pacella J Nanotheranostics. 2022; 6(2):215-229.
PMID: 34976596 PMC: 8671954. DOI: 10.7150/ntno.62351.